Gedeon Richter PLC (BUD:RICHTER)

Market Cap	1.79T
Revenue (ttm)	901.32B
Net Income (ttm)	227.29B
Shares Out	182.38M
EPS (ttm)	1,241.29
PE Ratio	7.91
Forward PE	6.66
Dividend	508.56 (5.24%)
Ex-Dividend Date	Jun 3, 2025

Volume	228,175
Average Volume	251,349
Open	9,750.00
Previous Close	9,710.00
Day's Range	9,700.00 - 9,935.00
52-Week Range	9,380.00 - 11,150.00
Beta	0.23
RSI	51.89
Earnings Date	Feb 27, 2026

About Gedeon Richter

Gedeon Richter PLC researches, develops, manufactures, markets, and sells pharmaceutical products. The company offers women’s healthcare products for contraceptives, endometriosis, fertility, menopause, vaginal infections, and uterine fibroids, as well as Femtech, a digital therapeutic solution to enhance women’s lives. It also provides central nervous system products, such as products for the treatment of chronic cerebral circulatory disorders and neuropathic pain; and anaesthetics, anti-anxiety medications, sleeping pills, and anti-epileptic ...

• Industry: Pharmaceutical Preparations
• Founded: 1901
• Employees: 10,943
• Stock Exchange: Budapest Stock Exchange
• Ticker Symbol: RICHTER

Financial Performance

In 2024, Gedeon Richter's revenue was 857.55 billion, an increase of 6.51% compared to the previous year's 805.16 billion. Earnings were 239.24 billion, an increase of 50.61%.